Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 57.40
-1.80 (-3.04%)
Aug 4, 2025, 4:25 PM CET
Elevation Oncology Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 885.24 million as of August 4, 2025. Its market cap has increased by 8.30% in one year.
Market Cap
885.24M
Enterprise Value
808.15M
Revenue
163.38M
Ranking
n/a
PE Ratio
21.70
Stock Price
$57.40
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 885.24M, an increase of 205.66%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 885.24M | 46.43% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | 839.95M | -12.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.18B |
| Nordhealth AS | 3.04B |
| Photocure ASA | 1.68B |
| Vistin Pharma ASA | 1.08B |
| Omda AS | 1.04B |
| ArcticZymes Technologies ASA | 939.71M |
| Thor Medical ASA | 870.72M |
| Lytix Biopharma AS | 607.53M |